There is a futile cycle of pump and leak of protons across the mitochondrial inner membrane. The contribution of the proton cycle to standard metabolic rate is signi®cant, particularly in skeletal muscle, and it accounts for 20% or more of the resting respiration of a rat. The mechanism of the proton leak is uncertain: basal proton conductance is not a simple biophysical leak across the unmodi®ed phospholipid bilayer. Equally, the evidence that it is catalysed by homologues of the brown adipose uncoupling protein, UCP1, is weak. The yeast genome contains no clear UCP homologue but yeast mitochondria have normal basal proton conductance. UCP1 catalyses a regulated inducible proton conductance in brown adipose tissue and the possibility remains open that UCP2 and UCP3 have a similar role in other tissues, although this has yet to be demonstrated.
Introduction
Cellular energy conservation is not as effective as it could be because of energy losses at different steps. In the idealised resting state an animal does no net work on its environment and there is no net synthesis of macromolecules such as fats. As a result, all of the energy that is obtained from oxidation of stored fuels is released as heat, regardless of the particular pathways and processes that take place. In this resting state all pathways are components of futile cycles. Some of these cycles carry large¯ows and are more important than others in determining metabolic rate. In non-resting states net work may be done, and the balance between net production of macromolecules and thermogenesis can be very ®ne. The major futile cycles potentially provide important sites of regulation of this balance, and so may be crucially important in obesity.
In this paper we focus on one of the most important energy-dissipating cycles: the futile cycle of proton pumping and proton leak across the mitochondrial inner membrane. This natural uncoupling of mitochondria allows oxygen consumption without ATP synthesis. We address two main questions. First, what contribution does the proton cycle make to the respiration of cells and organisms? Is it trivial, or a signi®cant proportion of total oxygen consumption? Second, what is the mechanism of the proton conductance? In particular, do members of the uncoupling protein family have important roles to play in different tissues?
The leak of protons across the mitochondrial inner membrane Mitochondria were discovered to be the site of oxidative ATP synthesis in the 1940s. Careful isolation of mitochondria in particular media was essential for good ATP yield, and protocols were empirically improved to give good coupling of oxygen consumption to ATP synthesis. By the 1960s the chemiosmotic theory highlighted the reason: coupling requires an intact mitochondrial inner membrane to sustain the protonmotive force that is produced by the proton pumps of the electron transport chain and used to drive the ATP synthase and other coupled reactions. The respiratory control ratio measures the respiratory stimulation that occurs during ATP synthesis, and the highest ratios were obtained by the most careful workers. Perhaps the ideal preparation of mitochondria would have in®nite respiratory control, with no uncoupled respiration in the absence of ATP synthesis. These ideas led to the implicit view that the basal leak of protons across the mitochondrial membrane was a preparation artefact that did not occur in cells.
The properties of the basal proton conductance were established by Nicholls, 1 who showed that it was strongly non-ohmic. The proton leak current does not depend linearly on its driving force (protonmotive force or membrane potential) as described by Ohm's law, but is non-ohmic: proton conductance increased greatly at higher potentials. This is the relationship expected for non-catalysed ion diffusion across a phospholipid bilayer, 2 and found experimentally in arti®cial phospholipid membranes, 3, 4 so until recently the basal proton conductance was generally assumed to be a biophysical phenomenon not catalysed by speci®c proteins. However, several of the mitochondrial substrate carriers, such as the adenine nucleotide and glutamateaaspartate transporters, can catalyse a fatty-acid dependant proton leak, 5 although the physiological importance of these pathways is unclear.
It came as a surprise that brown adipose tissue mitochondria have an inducible proton conductance catalysed by an uncoupling protein, UCP1.
6 UCP1 mRNA and protein are induced by cold exposure in rodent brown adipose tissue, and there is overwhelming evidence that UCP1, when activated, catalyses rapid proton leak across the mitochondrial inner membrane, leading to physiologically important thermogenesis. ATP and GDP inhibit proton conductance by binding to a speci®c region near the C-terminus, and fatty acids stimulate proton conductance. The mechanism of fatty acid activation is disputed; fatty acid anions may be transported out of the matrix by UCP1 and return in the protonated form to catalyse a net proton conductance 7 or they may bind to a speci®c site and provide a catalytic group to allow protons to enter a proton channel in UCP1. 8 Brown adipose tissue mitochondria also display the usual basal proton conductance, and there is no evidence that this is regulated in amount or activity. UCP1 mRNA and protein are absent from other tissues, speci®cally from liver and muscle.
We draw a clear distinction between the two types of proton conductance discussed above. The basal proton conductance is found in all mitochondria and is routinely measured in the absence of fatty acids and added nucleotides. Its mechanism is unclear. The inducible proton conductance in brown adipose tissue mitochondria is strongly dependant on fatty acids and nucleotides, and is catalysed by UCP1.
The huge potential of agents that increase mitochondrial proton conductance as treatments for obesity was demonstrated in extensive clinical use in the 1930s. By 1934 it was estimated that 100 000 people in the USA alone had been treated with dinitrophenol, a classic uncoupler, with dramatic success. 9 However, occasional problems with cataracts and some fatal overdoses led to its withdrawal, 10 and despite (or because of) its great ef®cacy, the uncoupling strategy as a treatment for obesity dropped out of favour. More recently, attempts have been made to exploit the inducible proton conductance in brown adipose tissue as a more controllable uncoupler, and such attempts continue. Interest in exploiting other UCPs in this way is now very high.
Measurement of proton conductance
Radiolabel distribution cannot be used to monitor proton uptake into mitochondria because protons rapidly exchange with water and equilibrate across the membrane. Direct measurement of external or internal pH changes has been used, but because the mitochondrial matrix volume is small and the proton conductance highly non-ohmic, even small proton movements alter the driving force and may change the proton leak rate, so such assays are dif®cult and can be unreliable.
Mitochondrial respiration in the absence of ATP synthesis (state 4) drives only the proton leak, and gives a crude estimate of the proton conductance. However, state 4 respiration is controlled by both proton conductance and substrate oxidation 11 so changes in respiration can occur without changes in proton conductance, and vice versa, and interpretation must be cautious. For example, state 4 respiration (and proton cycling rate) will decrease if the electron transport chain is poisoned with submaximal cyanide even though the proton conductance is unaltered.
The steady-state mitochondrial potential drops if proton conductance rises, and measurement of this drop has recently become a popular surrogate for assay of proton conductance. 12 ± 15 However, the mitochondrial potential is controlled not only by the proton conductance, but also by substrate oxidation and ATP synthesis, 16 so a decrease in mitochondrial potential in response to an agent does not necessarily show that the agent uncouples, and once again, the assay is not speci®c and results must be interpreted very cautiously. For example, activation of a futile cycle that uses ATP, or inhibition of electron transport in a cell will both decrease the mitochondrial membrane potential even though the proton conductance may be unaltered.
A convenient qualitative assay can be carried out by monitoring the rate of swelling of mitochondria in appropriate isotonic salt solutions, where the swelling rate is limited by the proton¯ux. 17 However, the driving force for the proton leak is uncontrolled in such assays, and the proton conductance is nonlinearly dependent on the driving force, so such assays are not quantitative and comparisons between conditions can be misleading.
Leak¯uxes can also be estimated from PaO ratios (ATP synthesised per oxygen atom consumed) in vitro or in vivo. 18, 19 If the substrate remains the same, a drop in PaO ratio below the theoretical or control value is caused by diversion of the proton¯ux into the leak pathway.
We ®nd that the most convenient, reliable and accurate assay of proton conductance is to measure its kinetics. 1,20 ± 22 In the presence of oligomycin (a speci®c high-af®nity inhibitor of ATP synthesis) all of the oxygen consumption drives proton leak, so respiration is a measure of the steady state proton cycling rate. The relationship between respiration and proton pumping rate must be constant; it is in liver mitochondria and hepatocytes. 23 ± 25 The steady state protonmotive force is varied by titrating with electron transport inhibitors. A plot of respiration against protonmotive force is then a classical`v against [S]' plot of proton leak rate as a function of its`substrate', protonmotive force. Changes in proton conductance show up as shifts in the kinetic response to proton-motive force and as different lines on the graph, but changes in proton leak rate due only to changes in its driving force show up as unaltered kinetics with superimposed lines. This assay is quick and simple, yet reliable, accurate, and much less prone to misinterpretation than the indirect assays discussed above. We have used it in isolated mitochondria, in intact hepatocytes and other cells, and in perfused organs in situ. 20 ± 22,26 What proportion of respiration rate is used to drive the mitochondrial proton leak?
Once we know the kinetics of the proton leak we can calculate its rate from the protonmotive force even if ATP synthesis continues. In isolated mitochondria only a small proportion of state 3 respiration is used to drive the proton leak. However, near state 4, most of the respiration drives the leak. 20 Assay of mitochondrial proton conductance in hepatocytes shows that the basal proton leak exists in situ with similar rate and kinetics to those of isolated liver mitochondria. This shows that the proton leak measured in well coupled isolated mitochondria is not an artefact of isolation, but a physiological reaction. In resting hepatocytes about 26% of the respiration is used to drive the proton leak pathway. 21 If the cells are stimulated to make glucose and urea, so doubling their respiration, this proportion drops to about 22%. 27 In perfused resting rat hindquarter, the proton leak reaction is even more signi®cant, accounting for about 50% of respiration. 28 If some of the muscle is electrically stimulated to contract so that respiration doubles, the leak is still very important, accounting for about 34% of respiration. 27 If we multiply these values by literature estimates of the contribution of different organs to standard metabolic rate (SMR), we ®nd that 18 ± 22% of SMR can be attributed to mitochondrial proton leak, and about 14% of SMR and heat production is caused by proton leak in skeletal muscle alone. 27, 28 The errors in this estimate are signi®cant, but it seems hard to deny that the leak in muscle, liver and other tissues has a major role in whole animal oxygen consumption and thermogenesis.
Mechanism of the mitochondrial proton conductance
Except for the inducible proton conductance in brown adipose tissue mitochondria, which is catalysed by UCP1, the mechanism of proton leak is unclear. We will examine two hypotheses for the basal proton conductance in these and other mitochondria: a biophysical membrane bilayer conductance and a UCPcatalysed conductance. These hypotheses lie at opposite ends of a spectrum of possible mechanisms, ranging from a bilayer conductance enhanced by non-speci®c effects of local proteins, through leak at non-speci®c or speci®c protein-lipid interfaces in the membrane, through proton transport as the sum of the small rates of proton leak catalysed by each of the mitochondrial transporters, to proton leak catalysed by speci®c unidenti®ed proteins. 29 One way into this question is to ®nd conditions that change proton conductance to see what clues are revealed. There are two species-level effects that change the proton conductance of isolated mitochondria or mitochondria within hepatocytes: phylogeny and allometry. However, cell respiration also changes, and there is no alteration in the fractional contribution of proton leak to hepatocyte respiration, which remains at 20 ± 25%. We showed that a mammal (rat) had liver mitochondria with ®ve times higher proton conductance than a reptile (bearded dragon) even though the animals are the same size and have the same preferred body temperature. 30 Larger mammals (horse) had liver mitochondria with up to ®ve times lower proton conductance than smaller mammals (mouse). 31 There are also more acute effects that change the proton conductance of isolated mitochondria or mitochondria within hepatocytes: thyroid hormone status and perhaps metabolic depression. Thyroid hormones do alter the fractional contribution of proton leak to hepatocyte respiration and cause cellular respiration rate to change. Hyperthyroid rat liver mitochondria have ®ve times higher proton conductance than hypothyroids, 32 and this causes half of the difference in hepatocyte respiration. 33 Similarly, metabolic rates in hibernation and aestivation can be reduced six-fold or more, and mitochondrial proton leak may decrease here too.
A clue about the mechanism of these differences in proton permeability comes from variations in the fatty acid side-chains of the membrane phospholipids. The proton conductance of different mitochondria correlates with their phospholipid composition. 34 For example, over many different species and conditions the proton conductance correlates signi®cantly with the membrane phospholipid content of the polyunsaturated fatty acid docosahexaenoic acid (22:6n3, DHA). There are also (negative) correlations with other fatty acids such as 18:1n9. Together with the similarity between the kinetics of the proton leak in liposomes and mitochondria mentioned above, this suggests a natural hypothesis: that protons normally leak through the phospholipid bilayer and the bilayer composition affects the conductance (and is used by biology to regulate it).
We tested this biophysical model by isolating phospholipids from mitochondria with different proton conductance and phospholipid fatty acid composition, forming liposomes from these phospholipids in vitro, and measuring the liposome proton conductance. The proton conductances were the same despite a ten-fold difference in the proton permeability of the parent mitochondria and a thirty-fold difference in liposome phospholipid DHA content. 35 So the fatty acid composition of the membrane phospholipids does not affect the proton conductance in mitochondria by modifying leak through bulk phospholipid bilayer. However, the correlation between composition and proton leak remains intriguing, and it may yet turn out that phospholipid fatty acid composition controls the proton conductance of mitochondria through phospholipid-protein interactions with non-speci®c or with speci®c membrane proteins such as UCPs.
The proton conductance of liposomes made from mitochondrial phospholipids is between 3% (mouse) and 20% (bearded dragon) of the basal proton conductance of the parent mitochondria. 4, 31, 35 This relatively small difference between the liposome and mitochondrial conductances is low enough to be compatible with the hypothesis that mitochondrial leak is through the bilayer, but modi®ed by different conditions of local curvature, surface charge etc. However, it is also compatible with the other mechanistic hypotheses outlined above, and the observation that the mitochondrial proton conductance is up to 30 times the liposome conductance could be taken as evidence that there is a protein catalyst in the mitochondria. What is the evidence for and against the hypothesis that speci®c proteins catalyse the basal proton conductance of mitochondria?
The evidence for and against UCP1 homologues as catalysts of proton conductance
The discovery of homologues of UCP1 in other tissues 12, 13, 36, 37 has opened an exciting new chapter in the study of mitochondrial proton conductance and its potential manipulation in obesity and other conditions.
There are three main lines of evidence that support the hypothesis that UCP2 and UCP3 are natural uncouplers. 12, 13 First, they are closely related to UCP1 (this is how they were discovered); UCP2 is 59% identical to UCP1. Such close relationships suggest that UCP2 and UCP3 have the same function as UCP1. Second, the UCP1 homologues have a wide distribution. UCP2 is present in most tissues examined, so unlike UCP1, it could plausibly catalyse the basal proton conductance in many tissues. UCP3 is found mostly in skeletal muscle, raising hopes that it can be targeted pharmaceutically to uncouple speci®-cally and safely in obesity. The third line of evidence comes from the effects of UCP2 and UCP3 expressed in model systems, particularly yeast. The yeast grow more slowly on oxidisable substrates, and¯uorescent probe measurements indicate that the UCPs depolarise the mitochondria, as predicted if they uncouple. Mitochondria isolated from yeast expressing UCP2 have lower respiratory control than controls, as expected if UCP2 uncouples.
This evidence that UCP2 and UCP3 are natural uncouplers is quite strong and has been widely accepted, but it is not beyond criticism. Sequence similarity is good evidence for similar function, but is the comparison made with the correct UCP1 function? UCP1 is a nucleotide and fatty acid binding protein, perhaps a fatty acid carrier, and maybe its fatty aciddependant proton translocation is a recent addition.
Perhaps the true functional homology is with the fatty acid binding function: maybe UCP2 and UCP3 are fatty acid or ketone body carriers or binding proteins. Observations that mRNA levels of the UCP1 homologues correlate better with fatty acid metabolism than they do with thermogenesis 38 support this suggestion.
The effects in yeast could be caused by uncoupling, but alternatively, they could indicate damage to electron transport or ATP synthesis. Yeast with compromised mitochondria might grow more slowly and exhibit lower membrane potentials, and the isolated mitochondria could have lower respiratory control ratios, as observed.
Even if UCP2 and UCP3 do uncouple yeast mitochondria, there is unfortunately no assay to test whether this is a speci®c native function as there is with UCP1, which induces a proton conductance in yeast that is sensitive to GDP. 39 Such an assay is vital to distinguish speci®c effects of inserted UCPs from possible non-speci®c effects, and the experiments with UCP1 homologues will be greatly strengthened if speci®c inhibitors or activators become available. Published experiments do not quantify the amounts of foreign UCP1 homologues in the yeast mitochondria, so the membrane may have been overloaded with protein. Unlike a normal enzyme reaction, where the reappearance of the catalysed activity is an excellent indicator of correct reconstitution, the catalysis of proton conductance may not disappear, but instead is very likely to increase if a foreign protein folds incorrectly in the membrane. We can get some insight into this possibility from careful experiments in which physiologically relevant amounts of UCP1 were expressed in yeast mitochondria. 40 Only half of the UCP1 molecules inserted showed native GDP binding. There is some indication that the other half were folded wrongly and non-speci®cally increased the proton permeability of the yeast mitochondria: the respiration of UCP1-containing yeast mitochondria in the presence of GDP to inhibit the correctly-folded UCP1 was more than twice that of controls. 40 There is some evidence against the hypothesis that UCP1 homologues catalyse the basal proton conductance in mitochondria.
Despite their wide tissue distribution, the amounts of UCP2 or UCP3 mRNA do not correlate with the proton conductance in different tissues. Table 1 lists the measured basal proton conductance of mitochondria from different tissues, expressed per total tissue RNA to facilitate comparison with published mRNA levels. Rat kidney has more UCP2 mRNA than rat brain, but kidney mitochondrial proton conductance is much lower. Most striking is liver: hepatocytes contain no UCP2 or UCP3 (measured UCP2 mRNA in adult liver is from non-parenchymal cells), but their basal proton conductance is signi®cant, and it is hard to argue that liver basal proton conductance is catalysed by UCP2 or UCP3. Thyroid hormones alter the proton conductance of hepatocyte mitochondria more than six-fold, but UCP2 mRNA levels in whole liver do not change with thyroid status. Conversely, thyroid hormones change UCP3 mRNA levels in muscle substantially, 14,53 but there is little or no effect of hypothyroidism on the basal proton conductance of isolated rat muscle mitochondria (JS Ballantyne and MD Brand, unpublished).
These correlations can be criticised on two main grounds. First, mRNA levels do not report protein levels, and to infer quantitative differences in function from differences in mRNA is a dubious exercise. This is also a valid criticism of much of the work that is currently being published showing changes in mRNA for the UCPs under different conditions. Second, there could be other UCP1 homologues in liver, brain and other tissues that contribute to the proton conductance, so invalidating the comparisons: such homologues have been proposed but not yet published.
The question of undiscovered homologues can be answered de®nitively in yeast, where the complete genome is known. Figure 1 shows that the basal proton conductance is higher in yeast mitochondria than in rat liver mitochondria: at a given membrane potential the proton leak rate is about ®ve times greater. However, the yeast genome shows no protein that matches the UCPs better than it matches other members of the mitochondrial carrier protein family. Depending on the stringency of the criteria used, there are 32 ± 35 members of this carrier family in Saccharomyces cerevisiae. 55, 56 Table 2 lists all that score in the top six for similarity to human and plant UCPs or to the adenine nucleotide translocase. No yeast protein has more than 35% identity to any UCP, and the yeast proteins are as similar to the adenine nucleotide translocase as they are to the UCPs. The closest yeast homologue to the uncoupling proteins is the yeast dicarboxylate carrier, whose function is wellcharacterised. 55 The yeast and human adenine nucleotide translocases are genuine matches, and stand out prominently; they are 53 ± 55% identical. We conclude that the basal proton conductance in yeast mitochondria, which is similar to the basal conductance in various tissues in other species, is not catalysed by a speci®c homologue of the mammalian UCPs.
Other circumstantial evidence exists: UCP1 knockout mice overexpress UCP2 mRNA ®ve-fold in brown adipose tissue, but the isolated brown adipose mitochondria have the same basal proton conductance as controls where UCP1 is inhibited by GDP. 59 This suggests that UCP2 does not catalyse the basal protein conductance in brown adipose tissue (but UCP2 protein was not measured and might not have followed the change in mRNA). Also, replacement of two histidine residues in UCP1 abolishes proton transport, but UCP2 lacks this histidine pair, suggesting C. Rat liver mitochondria were incubated with rotenone and succinate, and titrated with malonate. Yeast mitochondria were incubated with myxothiazol, and titrated with lactate. Respiration rates were multiplied by 6 (liver) or 4 (yeast) to give proton leak rates. Membrane potentials were measured in the presence of nigericin using a TPMP-sensitive electrode assuming binding corrections of 0.4 mgaml (liver) or zero (yeast). For rat liver n 1; values were measured at 30 C and 37 C and scaled to the mean of our published values for rat liver at 37 C. 20 ± 22,26 For yeast n 9; error bars show s.e.m.
that it may not have the same proton translocating function. 60 
Conclusions
Mitochondrial proton conductance is not an artefact of isolation but occurs in cells and tissues. Natural uncoupling by the basal proton leak burns off signi®cant amounts of energy; we estimate that it is responsible for 20% or more of SMR. This makes it the most important single reaction that drives basal thermogenesis in mammals, and an excellent potential target of treatment of obesity. The mechanism of the basal proton conductance remains uncertain: it may be through the membrane bilayer as it exists in mitochondria, or it may be catalysed. In the light of the observations discussed above, it seems premature to conclude that the basal proton conductance that is found in all mitochondria is catalysed by homologues of UCP1. More unequivocal evidence is required before a clear statement can be made, and at present the question remains open.
The inducible proton conductance in brown adipose tissue is catalysed by UCP1, and is activated by fatty acids and inhibited by nucleotides. It remains an exciting possibility that UCP2, UCP3 and other less characterised UCPs catalyse an inducible proton conductance in other tissues. However, if they do so, the reaction has not been clearly observed in any experimental system, and the putative inducers and activators are currently unknown. Vigorous research is required to sort out the true roles of the UCP1 homologues. All Saccharomyces cerevisiae proteins were compared to the human uncoupling proteins (hUCPs), plant uncoupling protein (stUCP) 58 and human adenine nucleotide translocase (hANT). BLASTp scores are shown in parentheses (the most similar yeast protein scores 1, etc.) followed by amino acid % identity and amino acid % identity allowing conservative substitutions. NR not ranked, that is ranking is below the BLASTp program cutoff level. Designations of yeast protein functions are those in the database.
